Literature DB >> 31398967

Prescription Opioid Use among Pregnant Women Enrolled in Rhode Island Medicaid.

Xuerong Wen1, Nicholas Belviso1, Rebecca Lebeau2, Jeff Bratberg1, Brandi Cotton3, Kristina Ward1, Debra Erickson-Owens3, Stephen Kogut1.   

Abstract

OBJECTIVE: Our objective was to identify patterns of opioid use among pregnant women enrolled in RI Medicaid.
METHODS: This study used linked RI Medicaid and RI Birth Certificate data from 01/01/2006 to 12/31/2016. We examined temporal trends of prescription opioid dispensings and identified risk factors associated with opioids use during pregnancy.
RESULTS: Among 25,500 RI Medicaid enrolled pregnant women who delivered a live baby from 2008 to 2016, 1,914 (7.5%) received at least one prescription for an opioid medication during pregnancy, 810 (3.2%) were during the first trimester, 633 (2.5%) during the second trimester, and 866 (3.4%) during the third trimester. Of these, 213 (0.8%) women received 3 or more opioids during pregnancy. The prevalence of prescription opioids dispensed in pregnant women increased from 4.9% in 2008 to 9.6% in 2015 (β±SD: 0.66±0.28, P=0.05).
CONCLUSIONS: Prescription opioid use during pregnancy has increased among women enrolled in RI Medicaid.

Entities:  

Keywords:  RI Medicaid; opioid analgesics; pregnant women

Mesh:

Substances:

Year:  2019        PMID: 31398967      PMCID: PMC7000235     

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  13 in total

1.  Prescription Opioids in Pregnancy and Birth Outcomes: A Review of the Literature.

Authors:  Mahsa M Yazdy; Rishi J Desai; Susan B Brogly
Journal:  J Pediatr Genet       Date:  2015-04-01

2.  Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes.

Authors:  Ayumi Maeda; Brian T Bateman; Caitlin R Clancy; Andreea A Creanga; Lisa R Leffert
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

3.  Low back pain and pelvic pain during pregnancy: prevalence and risk factors.

Authors:  Ingrid M Mogren; Anna I Pohjanen
Journal:  Spine (Phila Pa 1976)       Date:  2005-04-15       Impact factor: 3.468

4.  Headache during pregnancy.

Authors:  F Maggioni; C Alessi; T Maggino; G Zanchin
Journal:  Cephalalgia       Date:  1997-11       Impact factor: 6.292

5.  Opioid growth factor and organ development in rat and human embryos.

Authors:  I S Zagon; Y Wu; P J McLaughlin
Journal:  Brain Res       Date:  1999-08-28       Impact factor: 3.252

6.  Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; James P Rathmell; John D Seeger; Michael Doherty; Michael A Fischer; Krista F Huybrechts
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

7.  Trends in Medical Use of Opioids in the U.S., 2006-2016.

Authors:  Brian J Piper; Dipam T Shah; Olapeju M Simoyan; Kenneth L McCall; Stephanie D Nichols
Journal:  Am J Prev Med       Date:  2018-03-15       Impact factor: 5.043

8.  Exogenous hormones and other drug exposures of children with congenital heart disease.

Authors:  K J Rothman; D C Fyler; A Goldblatt; M B Kreidberg
Journal:  Am J Epidemiol       Date:  1979-04       Impact factor: 4.897

9.  Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study.

Authors:  Mark D Sullivan; Mark J Edlund; Ming-Yu Fan; Andrea DeVries; Jennifer Brennan Braden; Bradley C Martin
Journal:  Pain       Date:  2008-06-10       Impact factor: 6.961

Review 10.  Chronic pain during pregnancy: a review of the literature.

Authors:  Shona L Ray-Griffith; Michael P Wendel; Zachary N Stowe; Everett F Magann
Journal:  Int J Womens Health       Date:  2018-04-09
View more
  3 in total

1.  Maternal Complications and Prescription Opioid Exposure During Pregnancy: Using Marginal Structural Models.

Authors:  Xuerong Wen; Shuang Wang; Adam K Lewkowitz; Kristina E Ward; Erin Christine Brousseau; Kimford J Meador
Journal:  Drug Saf       Date:  2021-10-05       Impact factor: 5.606

2.  Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.

Authors:  Xuerong Wen; Nicholas Belviso; Emily Murray; Adam K Lewkowitz; Kristina E Ward; Kimford J Meador
Journal:  JAMA Netw Open       Date:  2021-04-01

3.  Prevalence and duration of prescribed opioid use during pregnancy: a cohort study from the Quebec Pregnancy Cohort.

Authors:  Jin-Ping Zhao; Christelle Berthod; Odile Sheehy; Behrouz Kassaï; Jessica Gorgui; Anick Bérard
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-01       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.